Crédits

3 Credits Swiss Society of General Internal Medicine

As you know, hepatocellular carcinoma is a challenge. Too often patients are diagnosed at an advanced stage; often patients are not referred based on a nihilistic attitude which should belong to the past. Several therapeutic options are available and to select the best for each patient requires expertise.

For the benefit of our patients we plan to organize a HCC Online Update starting at 14:00 on the 31th March 2022 focusing on hepatocellular carcinoma and bringing together the different specialties.
This event will have CME recognition.

Programme

14:00-14:10

Prof. Dufour, Lausanne
Opening

14:10-14:45

I. Labgaa, Lausanne
Time to get more information from the blood

14:45-15:20

T. Koessler, Genève
What after immunotherapy

15:20-15:55

Prof. J. Calderaro, Paris
How histology impacts on HCC management

15:55-16:15

Break

16:15-16:45

Recipient Price

16:45-17:20

M. Pinter, Vienna
Predictors of response to therapy

17:20-17:55

Prof. G. Abou-Alfa, New York
What is coming as new therapies

17:55-18:10

Prof. Dufour, Lausanne
Closing remarks

18:10-19:00

Networking

    Entrer votre adresse e-mail pour rester en contact avec la Fondation